现代消化及介入诊疗
現代消化及介入診療
현대소화급개입진료
MODERN DIGESTION & INTERVENTION
2014年
6期
368-372
,共5页
陈羽%吴礼浩%马伟钦%何兴祥
陳羽%吳禮浩%馬偉欽%何興祥
진우%오례호%마위흠%하흥상
他汀类药物%结直肠肿瘤%Meta分析%发病率
他汀類藥物%結直腸腫瘤%Meta分析%髮病率
타정류약물%결직장종류%Meta분석%발병솔
Statin%Colorectal neoplasms%Meta-analysis%Morbidity
目的:系统评价他汀类药物对结直肠癌的发病率及病死率的影响。方法使用Medline等数据库收集他汀类药物与结直肠肿瘤相关的文献,筛选高质量文献,分别计算RR或OR值以及95%CI等,分析他汀类药物预防结直肠癌及结直肠腺瘤的作用,运用漏斗图评价发表偏倚。结果共纳入30项研究,研究对象2417713例。他汀类药物预防结直肠癌的森林图提示存在统计学差异(RR=0.87,95%CI:0.77-0.99,P=0.03),他汀类药物预防结直肠腺瘤的森林图不存在统计学差异(OR=0.61,95%CI:0.31-1.22,P=0.16),漏斗图分析各项研究未发现发表偏倚。结论他汀类药物对结直肠癌可能起到一定的化学预防作用,而对结直肠腺瘤的作用有待进一步研究。
目的:繫統評價他汀類藥物對結直腸癌的髮病率及病死率的影響。方法使用Medline等數據庫收集他汀類藥物與結直腸腫瘤相關的文獻,篩選高質量文獻,分彆計算RR或OR值以及95%CI等,分析他汀類藥物預防結直腸癌及結直腸腺瘤的作用,運用漏鬥圖評價髮錶偏倚。結果共納入30項研究,研究對象2417713例。他汀類藥物預防結直腸癌的森林圖提示存在統計學差異(RR=0.87,95%CI:0.77-0.99,P=0.03),他汀類藥物預防結直腸腺瘤的森林圖不存在統計學差異(OR=0.61,95%CI:0.31-1.22,P=0.16),漏鬥圖分析各項研究未髮現髮錶偏倚。結論他汀類藥物對結直腸癌可能起到一定的化學預防作用,而對結直腸腺瘤的作用有待進一步研究。
목적:계통평개타정류약물대결직장암적발병솔급병사솔적영향。방법사용Medline등수거고수집타정류약물여결직장종류상관적문헌,사선고질량문헌,분별계산RR혹OR치이급95%CI등,분석타정류약물예방결직장암급결직장선류적작용,운용루두도평개발표편의。결과공납입30항연구,연구대상2417713례。타정류약물예방결직장암적삼림도제시존재통계학차이(RR=0.87,95%CI:0.77-0.99,P=0.03),타정류약물예방결직장선류적삼림도불존재통계학차이(OR=0.61,95%CI:0.31-1.22,P=0.16),루두도분석각항연구미발현발표편의。결론타정류약물대결직장암가능기도일정적화학예방작용,이대결직장선류적작용유대진일보연구。
Objective Aim of this study is to explore the association between statin use and colorectal neoplasm risk through meta-analysis based on published studies. Methods A comprehensive literature search was undertaken through August 2014 looking for eligible studies through Medline and so on. Pooled relative risk (RR) estimates and 95%confidence intervals (CIs) were used to calculate estimated effect. Then, the po-tential presence of publication bias and study heterogeneity was assessed. Result A total of 30 studies, involv-ing 2,417,713 subjects, contributed to the analysis. Overall, statin use was associated with a modest reduction in the risk of colorectal cancer (RR=0.87, 95%CI:0.77-0.99, P=0.03). However, we did not find significant evidence of statin use and colorectal adenoma (OR=0.61, 95%CI:0.31-1.22, P=0.16). Publication bias was not be detected by the funnel plot. Conclusion Statin use was associated with a modest reduced risk of col-orectal cancer. However, further targeted research of the association between statin and colorectal adenoma is warranted.